BioWorld

Feb. 9, 1994

View Archived Issues

PHARMOS COMPLETES PHASE II TRIAL OF GLAUCOMA DRUG

Read More

IMMUNOGEN'S UNDERWRITERS EXERCISE OPTION

Read More

SPECTRAL LICENSES CDNA CLONES

Read More

CARRINGTON EXPANDS WOUND DRESSING LINE

Read More

PANEL SAYS THROMBOLYTICS ARE UNDERUTILIZED

Read More

FDA RELEASES BST LABELING GUIDELINES

Read More

ONCOGENE INKS PACT TO DEVELOP LEAD COMPOUNDS

Read More

PHARMOS COMPLETES PHASE II TRIAL

Read More

PRICE CONTROLS DRAW CRITICISM

Read More

SIGNAL RAISES $6.1M IN FIRST VENTURE ROUND

Read More